Clinical Trials
10 trialsNCT05819008 2026-04-01
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
Umeå University
Recruiting
NCT06788886 2025-12-30
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mayo Clinic
Phase NA Recruiting
NCT06322342 2025-12-26
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Phase 2 Completed
NCT02670161 2025-08-24
Quality Improvement and Practice Based Research in Neurology Using the EMR
Endeavor Health
Phase 4 Enrolling by invitation
NCT05017142 2024-12-16
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
University of Bern
Recruiting
NCT06583395 2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
NCT06330298 2024-04-16
T-ScEmo4ALL
University Medical Center Groningen
Phase NA Unknown
NCT06251830 2024-02-09
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
IRCCS Fondazione Stella Maris
Completed
NCT03840928 2023-12-13
PatientSpot Formerly Known as ArthritisPower
Global Healthy Living Foundation
Unknown
NCT02967380 2017-03-27
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
University of Southern California
Phase NA Terminated